Searched for
STERILE PARENTERAL
Amanta Healthcare shares jump another 5% after a decent debut. Should you book profits or hold?Amanta Healthcare shares extended gains after debuting at a 7% premium, reflecting moderate investor optimism despite steep valuations at 4...- Amanta Healthcare shares to list tomorrow. Here's what GMP indicates ahead of debutAmanta Healthcare, an Ahmedabad-based pharmaceutical company, is set to debut on the market with modest expectations, indicated by a GMP of...
- Amanta Healthcare IPO subscribed nearly 83 times at close; GMP at 8%. Should you bid?Amanta Healthcare’s Rs 126 crore IPO was subscribed nearly 83 times at close, driven by NIIs and RIIs. Trading at an 8% GMP, the stock may ...
- Amanta Healthcare IPO subscribed 12.40 times on Day 2; GMP at 12% — Should you bid? Check key detailsAmanta Healthcare's Rs 126 crore IPO witnessed strong investor demand, subscribing 12.40 times on its second day, driven by retail investor...
- Amanta Healthcare IPO subscribed 3.2 times so far on Day 1; GMP at 15%. Should you bid?Amanta Healthcare's IPO witnessed strong investor demand, being oversubscribed 3.2 times on its opening day, driven by retail and non-insti...
- Eris acquires 51 pc stake in Swiss Parenterals for Rs 637.5 crEris Lifesciences on Tuesday said it has acquired a 51 per cent stake in Swiss Parenterals for Rs 637.5 crore. Ahmedabad-based Swiss Parent...
- Aurobindo Pharma under USFDA scrutinyAurobindo has seen intense scrutiny on the manufacturer process of valsartan, an anti-hypertension drug, that was found to contain carcinog...
- Sun pharma invests 120 crore in Assam to set up production lineAccording to statement from Assam government the company has already invested Rs 700 crore in this manufacturing facility in the state and ...
- Sun Pharma needs to fix leaking roof, contamination risks at Halol: USFDAThe US FDA has directed Sun Pharma to systematically improve the oversight of manufacturing quality to ensure sustainable quality assurance.
- Swedish firm Recipharm buys majority stake in Nitin Lifesciences for Rs 671 croreSwedish contract drug manufacturing firm Recipharm has acquired a 74% stake in Nitin Lifesciences, a privately held sterile injectables man...
- Claris Lifesciences completes transfer of Speciality Injectable BusinessShareholders of the company approved the transfer along with all employees, assets and liabilities at a consideration not less than its boo...
- South Africa approves six Marck Biosciences pharma productsThe South African market worth around $ 3.8 billion (2011), is growing at the rate of six per cent and is expected to reach $ 7 billion by ...
- South Africa drug authority approves Marck's 6 productsSix products have obtained approvals from MCC-South Africa, including Sterile Water for injections and Ciprofloxacin Eye Drops among others.
- Jubilant Life bags $90 million contract for parenteral productsJubilant Life Sciences today said it has secured contracts worth more than $90 million (over Rs 440 crore) from four life sciences firms.
- Dishman acquires Creapharm Parenterals for undisclosed amountDishman Pharma and Chemicals today said its Switzerland-based subsidiary has acquired Creapharm Parenterals for an undisclosed amount.
- Claris receives MHRA approval for Ahmedabad unitClaris Lifesciences Limited today announced that it has received approval for its plant at Ahmedabad from the MHRA of the United Kingdom.
- Pharma cos inject capacities to meet growing demandIndian pharmaceutical companies with a presence in sterile injectables space are expanding capacities to cater to growing demand in this se...
- Jubilant set to buy Draxis for Rs 1,020 crThis is the Delhi company's sixth buy and its first in Canada. Last year, it acquired Hollister Stier in the US for $125 million.
- The needle of life for Claris LifesciencesClaris Lifesciences’ niche lies in developing cheap injectibles.
- Jubilant to buy US co for $123mJubilant Organosys is acquiring US-based contract research and manufacturing services (CRAMS) company Hollister-Stier Labora-tories LLC for...
Load More
